Status:
COMPLETED
The Clinical Effect of MK0476 With Concomitant Administration of and Removal of Inhaled Beclomethasone in Asthmatic Patients (0476-029)
Lead Sponsor:
Organon and Co
Conditions:
Asthma
Eligibility:
All Genders
15-85 years
Phase:
PHASE3
Brief Summary
This study will investigate the additive effect of montelukast (MK0476) taken along with inhaled beclomethasone versus inhaled beclomethasone alone.
Eligibility Criteria
Inclusion
- Female patients tested negative for pregnancy and agreed to use appropriate contraceptives through out the study
- Patient was a nonsmoker
- Patient was in good general health (except for asthma)
Exclusion
- Patient was hospitalized
- Patient was female who was less than 8 weeks postpartum or breast feeding
- Patient planned to move or vacation away during the study
- Patient had major surgery within 4 weeks the past 4 weeks
- Patient has donated blood or participated in a clinical trial within the past 4 weeks
- Patient was a regular user or recent abuser of alcohol or illicit drugs
- Patient was 40% over or under normal weight for height
Key Trial Info
Start Date :
March 1 1995
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 1996
Estimated Enrollment :
642 Patients enrolled
Trial Details
Trial ID
NCT00911547
Start Date
March 1 1995
End Date
May 1 1996
Last Update
February 3 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.